Cardioprotection after percutanous intramyocardial injection of erythropoietin in hibernating myocardium;Kardioprotektion durch perkutane intramyokardiale injektion von erythropoeitin im hibernierenden myokard

Zeitschrift fur Herz-, Thorax- und Gefasschirurgie

Volumn 20, Issue 2, 2006, Pages 53-59

  Krause, K ^a   Jaquet, K ^d   Geidel, S ^a   Schneider, C ^a   Mandel, C ^b   Schiele, W ^b   Nauertz, M ^a   Stoll, H P ^c   Schmeller, M L ^b   Lass, M ^a   Ostermeyer, J ^a   Kuck, K H ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Clinical Research   (Belgium)

^d European Head Quarter ^*

Author keywords

Cardioprotection; Erythropoietin; Mapping

Indexed keywords

ERYTHROPOIETIN;

ANGIOCARDIOGRAPHY; ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; ECHOCARDIOGRAPHY; EDEMA; ERYTHROID PRECURSOR CELL; HEART MUSCLE INJURY; HEART PROTECTION; HISTOLOGY; HUMAN; MORPHOMETRICS; MYOCARDIAL HIBERNATION; NECROSIS; NEUROPROTECTION; NICK END LABELING; PLEIOTROPY;

EID: 33646748308     PISSN: 09309225     EISSN: 14351277     Source Type: Journal    
DOI: 10.1007/s00398-006-0531-7     Document Type: Article

References (19)

1. Masuda S, Nagao M, Takahata K et al (1993) Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 268:11208-11216
2. Sasaki R, Masuda S, Nagao M (2000) Erythropoietin: multiple physiological functions and regulation of biosynthesis. Biosci Biotechnol Biochem 64: 1775-1793
3. Brines ML, Ghezzi P, Keenan S et al (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97:10526-10531
4. Parsa CJ, Kim J, Kiel R et al (2004) Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. J Biol Chem 279:20655-20662. Epub 2004 Mar 11
5. Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck KH (2002) Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 64:326-333
6. Jelkmann W, Wagner K (2004) Beneficial and ominous aspects of the pleiotropic action of erythropoietin Ann Hematol 83:673-686. Epub 2004 Aug 21
7. Cai Z, Manalo DJ, Wei G et al (2003) Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108:79-85
8. Tramontano AF, Muniyappa R, Black AD, Blendea MC, Cohen I, Deng L, Sowers JR, Cutaia MV, El-Sherif N (2003) Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun 308:990-994
9. Gepstein L, Hayam G, Ben-Haim SA (1997) A novel method for non-fluoroscopic catheter-based electro-anatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation 9:1611-1622
10. Botker HE, Lassen IF, Hermansen F et al (2001) Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy. Circulation 103:1631-1637
11. Wiggers H, Botker HE, Sogaard P et al (2003) Electromechanical mapping versus positron emission tomography and single photon emission computed tomography for the detection of myocardial viability in patients with ischemic cardiomyopathy. Am Coll Cardiol 41:843-848
12. Hsia HH, Callans DJ, Marchlinski FE (2003) Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation 108:704-710. Epub 2003 Jul 28
13. Cordell JL, Falini B, Erber W et al (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219-229
14. Parsa CJ, Matsumoto A, Kim J et al (2003) A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 112:999-1007
15. Calvillo L, Latini R, Kajstura J et al (2003) Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling (2003) Proc Natl Acad Sci USA 100:4802-4806. Epub Mar 27
16. Kajstura J, Cheng W, Reiss K et al (1996) Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 7:86-107
17. Ausma J, Thone F, Dispersyn G et al (1998) Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant. Mol Cell Biochem 186:159-168
18. Elsasser A, Vogt AM, Nef H et al (2004) Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J Am Coll Cardiol 43:2191-2199
19. Elsasser A, Decker E, Kostin S et al (2000) A self-perpetuating vicious cycle of tissue damage in human hibernating myocardium. Mol Cell Biochem 213:17-28